It is here described a protein which is at least one SUMO protein, or a variant or a fragment thereof or a fusion protein comprising the same for use in the treatment of neurodegenerative and/or neurological disorders. In a further embodiment, it is here described a pharmaceutical composition comprising a protein which is at least one SUMO protein or a variant or a fragment thereof or a fusion protein comprising the same and pharmaceutically acceptable carriers.

SUMO and uses thereof

Colnaghi L;
2016-01-01

Abstract

It is here described a protein which is at least one SUMO protein, or a variant or a fragment thereof or a fusion protein comprising the same for use in the treatment of neurodegenerative and/or neurological disorders. In a further embodiment, it is here described a pharmaceutical composition comprising a protein which is at least one SUMO protein or a variant or a fragment thereof or a fusion protein comprising the same and pharmaceutically acceptable carriers.
2016
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/119303
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact